Finanzen von Minerva Neurosciences Inc (NERV)NERVMinerva Neurosciences Inc

In the context of the broader market, NERV competes directly with industry leaders such as TNXP and TARA. With a market capitalization of $259.27M, it holds a leading position in the sector. When comparing efficiency, NERV's gross margin of N/A stands against TNXP's 94.81% and TARA's N/A. Such benchmarking helps identify whether Minerva Neurosciences, Inc is trading at a premium or discount relative to its financial performance.

Minerva reported a Q1 non-GAAP EPS of -0.17, missing expectations, and a GAAP EPS of -25.51, highlighting ongoing financial struggles. However, the company has a current ratio of 20.14, indicating strong liquidity to cover short-term liabilities.